Progress and Prospects in Parkinson's Research/Therapy/Neuroprotection/Probucol
Probucol is a lipid-lowering phenolic compound with anti-inflammatory and antioxidant properties that has been recently reported as protective in neurotoxicity and neurodegeneration models.
Research
[edit | edit source]2013
Ribeiro et al [1] Swiss mice were treated with probucol during 21 days (11.8 mg/kg; oral route). Two weeks after the beginning of treatment, mice received a single intracerebroventricular (i.c.v.) infusion of 6-hydroxydopamine (6-OHDA).
On the 21st day, locomotor performance, striatal oxidative stress-related parameters, and striatal tyrosine hydroxylase and synaptophysin levels, were measured as outcomes of toxicity. 6-OHDA-infused mice showed hyperlocomotion and a significant decrease in striatal tyrosine hydroxylase (TH) and synaptophysin levels. In addition, 6-OHDA-infused mice showed reduced superoxide dismutase activity
Further Reading
[edit | edit source]Sub Pages:
- Substances with possible neuroprotective properties:
- Caffeine,--Celastrol,--Co-Enzyme Q10,--Creatine,--DHA,--Exendin-4 (EX-4),--GDNF,--Glutathione (GSH),--GM1,--Isradipine,--Melatonin,--Minocycline,--Nicotine,--NSAIDs,--Phenylbutyrate,--Phytic Acid,--Probucol,--Quinoxaline,--Rasagiline,--Riboflavin,--Statins,--Tolcapone,--Urate & Uric Acid,--Vitamin D,--Vitamin E,--
References
[edit | edit source]- ↑ Ribeiro, R.P.; Moreira, E.L; Santos, D.B,.; Colle, D.; Dos Santos, A.A.; Peres, K.C.; Figueiredo, C.P. and Farina, M. (2013) Abstract Neurochem. Res. 2013 Jan 19. Probucol Affords Neuroprotection in a 6-OHDA Mouse Model of Parkinson's Disease. http://www.ncbi.nlm.nih.gov/pubmed/23334712